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Available online 19 July 2014Abstract The adult mammalian heart was once believed to be a post-mitotic organ without any capacity for regeneration,
but recent findings have challenged this dogma. A modified view assigns the mammalian heart a measurable capacity for
regeneration throughout its lifetime, with the implication that endogenous regenerative capacity can be therapeutically
stimulated in the injury setting. Although extremely limited in adult mammals, the natural capacity for organ regeneration is a
conserved trait in certain vertebrates. Urodele amphibians and teleosts are well-known examples of such animals that can
efficiently regenerate various organs including the heart as adults. By understanding how these animals regenerate a damaged
heart, one might obtain valuable insights into how regeneration can be augmented in injured human hearts. Among the
regenerative vertebrate models, the teleost zebrafish, Danio rerio, is arguably the best characterized with respect to cardiac
regenerative responses. Knowledge is still limited, but a decade of research in this model has led to results that may help to
understand how cardiac regeneration is naturally stimulated and maintained. This review surveys recent advances in the field
and discusses current understanding of the endogenous mechanisms of cardiac regeneration in zebrafish.
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Acute myocardial infarction (MI), typically caused by coronary
artery occlusion and ischemia, is a leading cause of death
worldwide. For those fortunate enough to survive MI, necrotic
muscle induces amassive inflammatory response that activates
reparative mechanisms including recruitment and activation of
local fibroblasts, leading to the replacement of lost myocardi-
um with collagen-rich scar tissue. The scar provides a rapid
solution to cardiac injury by stabilizing the wound area;
however it is not contractile and weakens cardiac output,
increases susceptibility to aneurysm, induces compensatory
pathology and eventually leads to heart failure. Therapies that
facilitate survival or replacement of myocardium after ische-
mic injury in the human heart are urgently needed and would
have enormous social and economic impact.
Patients with acute MI represent a significant test-bed for
regenerative medicine. In principle, cardiomyocytes could be
generated from a variety of cellular sources and transplanted
into damaged tissues to restore functional myocardium. To
date, multiple endogenous stem and progenitor cell popula-
tions have been isolated from the postnatal mammalian heart
and these cells to varying degrees can differentiate into
cardiomyocytes when transplanted into infarcted hearts (Bearzi
et al., 2007; Beltrami et al., 2003; Bu et al., 2009; Chong et al.,
2011; Ellison et al., 2013; Goumans et al., 2007; Hierlihy et al.,
2002; Laugwitz et al., 2005; Matsuura et al., 2004; Messina et
al., 2004; Oh et al., 2003; Pfister et al., 2010; Smith et al., 2007;
Uchida et al., 2013; van Berlo et al., 2014; Ye et al., 2012).
Other promising sources for generating cardiomyocytes in vitro
are embryonic stem cells (He et al., 2003; Kattman et al., 2006;
Kehat et al., 2001; Mummery et al., 2003; Yang et al., 2008) and
induced pluripotent stem cells (Mauritz et al., 2008; Narazaki et
al., 2008; Zhang et al., 2009), which have been used for treating
damaged hearts in animal models (Chong et al., 2014;
Laflamme et al., 2007). Cardiac stem and progenitor cells
are extremely rare populations which diminish in quality
with age, which makes it reasonable to explore other
cellular targets for regenerative therapies. The epicardium,
a mesothelial layer covering the heart, has been shown to
be capable of contributing to the myocardial lineage at low
frequency in infarcted mouse hearts pretreated with the
natural secreted signaling peptide Thymosin β4 (Smart et
al., 2011). More recently, cardiac fibroblasts have been
induced to transdifferentiate into cardiomyocytes in vitro and
in vivo when defined cardiac transcription factors (Ieda et al.,
2010; Nam et al., 2013; Qian et al., 2012; Song et al., 2012) or
miRNAs (Jayawardena et al., 2012) are overexpressed.
An alternative approach would be to identify successful
examples of organ regeneration in nature, dissect theirmechanisms, and then attempt to apply gained insights to
humans via the provision of the appropriate regenerative
stimuli. Urodele amphibians and teleosts are well-known
examples of animals that possess remarkable regenerative
capacity in a variety of structures and organs as adults
(Brockes and Kumar, 2008; Poss, 2010). Among these, the
zebrafish (Danio rerio) is a relatively new experimental model
in regeneration biology, and has been quickly established as
the standard for investigating mechanisms of natural organ
regeneration, primarily due to its amenability to genetic
approaches. Zebrafish are highly regenerative as adults and
regrow injured or amputated tissues such as fins (Johnson
andWeston, 1995), maxillary barbel (LeClair and Topczewski,
2010), retinae (Vihtelic and Hyde, 2000), optic nerves
(Bernhardt et al., 1996), spinal cord (Becker et al., 1997),
heart muscle (Poss et al., 2002), brain (Kroehne et al., 2011),
hair cells (Ma et al., 2008), pancreas (Moss et al., 2009), liver
(Sadler et al., 2007), and kidney (Diep et al., 2011).
Although cardiac regeneration and repair have been
investigated in other teleost models (Grivas et al., 2014; Ito
et al., 2014; Lafontant et al., 2012), zebrafish arguably
display the most robust and best characterized cardiac
regenerative responses known to date among non-mammalian
vertebrate models (Chablais et al., 2011; González-Rosa et
al., 2011; Parente et al., 2013; Poss et al., 2002; Schnabel et
al., 2011; Wang et al., 2011). This review will summarize
recent advances in the field of regenerative medicine and
discuss cellular and molecular mechanisms underlying the
cardiac regenerative response in zebrafish.Origins of regenerated myocardium
Fate-mapping studies
Identifying cellular origins of regenerating tissues is a funda-
mental question in regeneration biology. Several studies have
performed fate-mapping analyses to investigate the cellular
origin(s) of cardiac muscle during heart regeneration in
zebrafish. By using inducible genetic fate-mapping techniques
(Buckingham and Meilhac, 2011), two studies directly exam-
ined the contribution of cardiomyocytes to the regenerating
zebrafish heart (Jopling et al., 2010; Kikuchi et al., 2010). In
both cases, two transgenic lines were used: one line carries
a 4-hydroxytamoxifen (4-HT) – inducible Cre recombinase
(CreER) gene fromwhich expression is driven in cardiomyocytes
by the promoter of the cardiac myosin light chain 2 (cmlc2)
gene, also known as myosin light chain 7 (myl7) gene; and the
other is an indicator line in which enhanced green fluorescent
protein (EGFP) reporter expression can be induced in CreER-
544 K. Kikuchiexpressing cells after excision of the loxP-flanked transcrip-
tional stop cassette by 4-HT treatments (Jopling et al.,
2010; Kikuchi et al., 2010). Using this system, almost all
cardiomyocytes expressing cmlc2 were pre-labeled with
EGFP by 4-HT treatments before injury, and regenerationFigure 1 New cellular sources for cardiac muscle. (A) A transgen
priZm cassette expresses a red fluorescent reporter protein (RFP)
Differential recombination between paired lox2272 (black triangle)
(CFP) or yellow fluorescent protein (YFP) expression, respectively. Th
the indicated cassette at a single genetic locus, and limited Cre-med
possible permanent colors with various combinations of RFP, CFP, an
of cardiomyocytes in the double transgenic context with the cmlc2
(Gupta and Poss, 2012). (B) Muscle lineages in the zebrafish ventricle
of primordial and cortical muscle cells. Arrows and arrowheads in the
the primordial muscle layer and the ventricular wall repaired by cort
The figure is a summary of the work by Poss and colleagues (Guptaexperiments were performed 30 days after ventricular resec-
tion. The results from both studies clearly showed that the
vast majority of regenerated myocardium is labeled with
EGFP, with no significant difference detected in the proportion
of EGFP+ cardiomyocytes in the regenerated tissue comparedic system for multicolor clonal labeling of cardiomyocytes. The
as a default color under the control of the β-actin2 promoter.
or loxP (white triangle) sites induces cyan fluorescent protein
e priZm transgenic strain carries multicopy tandem insertions of
iated excision events at the loxP or lox2272 sites produce many
d YFP expression. This strategy allows multicolor clonal labeling
:CreER strain (Kikuchi et al., 2010) after tamoxifen treatments
. Tr, trabecular muscle; Pr, primordial muscle. (C) Regeneration
middle and right panels indicate the edge of migrating clones of
ical muscular layer, respectively. Dotted line: amputation plane.
and Poss, 2012).
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cardiomyocytes, but not cmlc2− non-myocytes, are the major
source for new muscle during zebrafish heart regeneration.
Epicardial derived cells (EPDCs) have previously been
shown to contribute to and regulate vascularization during
cardiac regeneration in zebrafish (Kim et al., 2010; Lepilina
et al., 2006); however, their contribution to regenerating
myocardium has not been directly tested. Recent studies
have addressed this issue using two different approaches:
genetic fate-mapping (Kikuchi et al., 2011a) and transplan-
tation (González-Rosa et al., 2012). In the inducible genetic
fate-mapping study, the cis-regulatory sequences of transcrip-
tion factor 21 (tcf21), also known as Epicardin (Robb et al.,
1998), Pod1 (Quaggin et al., 1999), Capsulin (Hidai et al., 1998;
Lu et al., 1998), were used to target CreER to the zebrafish
epicardium (Serluca, 2008), and its progeny were traced during
regeneration following CreER-dependent labeling with EGFP,
which was induced from an indicator line with a transient 4-HT
treatment. In the transplantation assay, a piece of cardiac
tissue was collected from the injured ventricle of the β-actin:
EGFP strain, in which most cardiac cells, including epicardial
cells, were labeled with EGFP, and transplanted into a freshly
injured wild-type heart that had been irradiated prior to the
injury to suppress proliferation of cells in the recipient
tissue. In both studies, many fate-mapped cells were
detected in the regenerate and histologically characterized
asmyofibroblasts (González-Rosa et al., 2012) and perivascular
cells (González-Rosa et al., 2012; Kikuchi et al., 2011a), but
not as cardiomyocytes (González-Rosa et al., 2012; Kikuchi et
al., 2011a). These results indicate that epicardium or EPDCs do
not give rise to cardiac muscle during zebrafish heart
regeneration, which is consistent with the finding that
cardiomyocytes are the major source for regenerating
myocardium.
The lineage tracing experiments described above did not
address whether the cmlc2+ population includes multiple
muscle cell types that may contribute differently to regener-
ation. Recently, Poss and colleagues have generated a
transgenic system that allows multicolor clonal labeling of
cardiomyocytes, and defined previously uncharacterized myo-
cardial lineages, while revealing their behaviors during mor-
phogenesis of the zebrafish heart (Gupta and Poss, 2012).
This system consisted of two transgenic alleles, cmlc2:CreER
(Kikuchi et al., 2010) and a multicolor reporter cassette
termed priZm, which was constructed by utilizing the Brainbow
technology originally developed to visualize individual neurons
and connections in themouse brain (Livet et al., 2007) (Fig. 1A).
Using this system, the authors induced multicolor clonal
labeling at 2 days post fertilization, and performed image
analyses at various developmental stages to characterize in
detail how cardiomyocyte clones behave during morphogen-
esis of the heart.
The zebrafish ventricle has been recognized to contain
two types of cardiac muscle, comprising a peripheral wall
termed the compact layer and an inner trabecular layer (Hu
et al., 2001). Formation of trabeculae has been shown to
occur through delamination of cardiomyocytes from the
ventricular wall muscle (Liu et al., 2010). The clonal labeling
approach described above refined this anatomical and
developmental understanding of the zebrafish heart. First,
the authors found that the outer muscular wall of the
embryonic heart tube persists even in the adult ventricle. Toaccommodate cardiac growth, this muscle layer expands only
circumferentially throughout the life of the fish, maintaining a
single-cardiomyocyte thickness as seen in the embryonic
heart. Thismuscle lineage, termed primordial muscle, persists
to form the innermost layer of the peripheral muscular wall of
the adult ventricle (Fig. 1B, right panel). Second, the authors
observed that at the juvenile stage, the primordial muscle
layer is penetrated by a few trabecular cardiomyocyte
clones – ~8 clones per ventricle – as rare and spatially
segregated events, and these dominant cardiomyocyte clones
grow over the entire primordial layer, creating another
muscular wall that constitutes the outermost layer of the
peripheral muscular wall of the adult ventricle (Fig. 1B). This
muscle lineage is clearly distinct from the trabecular and
primordial muscle lineages, and has been termed the cortical
muscle layer. Thus, in the refined view, the adult zebrafish
ventricle consists of three different muscle lineages, primor-
dial, trabecular, and cortical muscle, and these lineages
develop in this temporal sequence during development (Gupta
and Poss, 2012).
After definition of the distinct muscle lineages, an interest-
ing question to ask is whether these lineages differentially
contribute to heart regeneration. The authors performed
regeneration experiments using ventricles of adult cmlc2:
CreER; priZm fish in which multicolor clonal labeling had been
induced at an embryonic stage as described above. At 14 days
post injury, cortical muscle clones adjacent to the wound
expanded in lateral and radial directions into the injury site, but
integration of primordial muscle cells did not occur at this time
point (Fig. 1C,middle panel). By 30 days after injury, as cortical
muscle reconstructed the muscular wall, clones of the
primordial muscle layer became detectable in the regenerate,
and a complete primordial layer was restored, forming a single
cell layer boundary between trabecular and regenerated
cortical muscle by 60 days after trauma (Fig. 1C, right
panel). Thus, both primordial and cortical muscle layers
contribute to the regenerate but they are formed in reverse
order compared to the sequence of normal development.
Primordialmuscle expands only circumferentially, as observed
during cardiacmorphogenesis, whereas corticalmuscle expands
in a less restricted manner and contributes the greater
mass of the new ventricular wall. This result is consistent
with the previous observation that regenerated muscle in
amputated hearts is primarily derived from a myocyte
sub-population in the lateral wall of the ventricle in which
the cardiogenic transcription factor gata4 is activated
(Kikuchi et al., 2010).
More recently, the same group has performed similar
multicolor clonal analyses on gata4+ and cmlc2+ cortical
muscle cells with labeling induced at the adult stage, and
these experiments revealed that unlike the initial ventric-
ular morphogenesis, there is no clonal-dominance in cortical
muscle cells during regeneration (Gupta et al., 2013), suggest-
ing that the proliferationmechanism utilized by cardiomyocytes
during regeneration is distinct from the one used during cardiac
development.Dedifferentiation
Dedifferentiation is a cellular process in which a specialized cell
reverts to an earlier developmental stage in response to a
546 K. Kikuchistimulus. Cardiomyocyte dedifferentiation, which is typically
characterized by a reduction of sarcomere structures and
expression of developmental marker genes, appears to be the
dominant mechanism for heart regeneration in zebrafish. In the
injured zebrafish heart, transmission electron microscopy and
immunofluorescence revealed that cardiomyocytes acquire a
less-organized sarcomeric structure in the regenerating area
(Jopling et al., 2010; Kikuchi et al., 2010). In addition, as
mentioned above, analysis using a reporter strain has shown
that most regenerating myocytes induce the regulatory
sequences of gata4, a gene essential for cardiac development,
and maintain this expression throughout the regeneration
process (Kikuchi et al., 2010). Together with the previous
observation that other embryonic cardiogenic genes are also
induced upon injury (Lepilina et al., 2006), the prevailingmodel
is that in response to injury, existing cardiomyocytes reduce
their contractile state to acquire an immature form in which
cell division is facilitated.
The dedifferentiation phenotypes described above are
reminiscent of those seen in embryonic mammalian
cardiomyocytes. Disassembly of sarcomere structures has
been shown as a feature of proliferating cardiomyocytes in
the embryonic mouse heart (Ahuja et al., 2004). Gata4
gene expression is also induced in myocardium during the
embryonic development of themouse heart, and its function is
required for cardiomyocyte proliferation (Zeisberg et al.,
2005). These results might suggest that mechanisms used for
regenerating the zebrafish heart are also conserved in the
mammalian hearts. It would be interesting to address how
injury stimulus can activate the regenerative mechanism in
the zebrafish heart and why such mechanism cannot be
re-activated in the postnatal mammalian heart to induce
cardiomyocyte proliferation.
The functional roles of the upregulated embryonic genes
in the regenerating zebrafish heart have not been fully
characterized, but a recent study has demonstrated that
Gata4 is essential for regeneration. Myocardial overexpres-
sion of a dominant-negative form of Gata4 induced an arrest
of regeneration after ventricular resection with collagenous
scar forming at the wound area. Interestingly, histological
analyses revealed that Gata4 inhibition specifically blocks
the proliferation of cortical cardiomyocytes, but not the
trabecular cardiomyocytes (Gupta et al., 2013), consistent
with the specific activation of the gata4 promoter in the
cortical area (Kikuchi et al., 2010).
Dedifferentiation characteristics are also detected in the
adult mammalian heart under some pathological situations.
Braun and colleagues investigated heart tissue samples from
chronic dilated cardiomyopathy patients to address what
factor(s) can cause dedifferentiated phenotypes in human
cardiomyocytes (Kubin et al., 2011). By using proteomics and
biochemical approaches, Oncostatin M (OSM), an interleukin-6
family cytokine with pleiotropic functions (Heinrich et al.,
2003; Tanaka and Miyajima, 2003), was found to be highly
expressed in hearts with dilated cardiomyopathy but not in
healthy hearts. The authors revealed that OSM induces loss of
sarcomeric structures and re-expression of fetal marker genes
in adult cardiomyocytes in vitro and in vivo through signals
mediated by the OSM receptor (Oβ). OSM could also enhance
cell cycle re-entry at least in neonatal cardiomyocytes in
vitro, and Oβ was required for the acquisition of dedifferen-
tiation phenotypes in cardiomyocytes at the border zone inthe infarctedmouse heart. Consistently, the activation of OSM
signaling led to increased animal survival after acute MI in the
mouse model. However, in a model of dilated cardiomyopa-
thy, the continuous activation of the OSM pathway reduced
both cardiac function and animal survival, which is possibly
due to the reduction of contractile force and the acceleration
of ventricular dilation by the persistence of dedifferentiated
cardiomyocytes (Kubin et al., 2011; Pöling et al., 2012, 2014).
Thus, the activation of dedifferentiation pathways alone may
not simply lead to regeneration inmammals, a notion thatmay
need to be considered as results obtained in zebrafish are
translated to clinically relevant situations.Transdifferentiation
Transdifferentiation is a regenerative phenomenon inwhich one
cell type converts to another, sometimes via an undifferenti-
ated intermediate. A classical example is during lens regener-
ation in adult newts, where a new lens is created by the dorsal
pigmented iris tissue (Eguchi et al., 1974; Grogg et al., 2005).
Given our understanding of the epigenetic stability of differen-
tiated states, it would seem that such a change would only
occur in developmentally related lineages, and so this phenom-
enon may not be commonly observed in other regeneration
models under natural conditions. However, it is increasingly
recognized that experimental manipulations can reprogram
epigenetic states, which was most notably demonstrated by the
induction of pluripotent stem cells (induced pluripotent stem
cells; iPSC) from adult somatic cells by expression of defined
transcription factors (Takahashi and Yamanaka, 2006). To date,
various cellular sources have been shown to transdifferentiate
into cardiomyocytes using similar strategies. By express-
ing combinations of cardiac transcription factors, cardiac
or dermal fibroblasts were shown to transdifferentiate
into cardiomyocytes in vitro (Ieda et al., 2010) and
non-cardiogenic mesoderm into beating myocardium in
vivo (Takeuchi and Bruneau, 2009). More recent studies
have demonstrated that the overexpression of transcrip-
tion factors (Nam et al., 2013; Qian et al., 2012; Song et
al., 2012) or miRNAs (Jayawardena et al., 2012) directly
induces lineage reprogramming of cardiac fibroblasts into
cardiomyocytes in vivo.
Interestingly, transdifferentiation can also occur natural-
ly to accommodate extreme loss of a particular cell lineage.
Upon genetic ablation of nearly all of the pancreatic β cells
in the adult mouse, glucagon-producing α cells, a distinct
endocrine cell type in the pancreas, gain the expression of β
cell specific transcription factors and differentiate into insulin
producing cells (Thorel et al., 2010). In a recent study, Chi and
colleagues have examined this phenomenon in the context of
cardiac regeneration, and discovered a novel regeneration
mechanism in the zebrafish heart (Zhang et al., 2013) (Fig. 2).
The authors first generated a genetic ablation model in which
the bacterial enzyme Nitroreductase is expressed only in
ventricular muscle under the control of regulatory se-
quences of the ventricular myosin heavy chain (vmhc)
gene. Nitroreductase can convert a prodrug into a cytotoxic
agent and its transgenic expression enables one to perform
cell type specific ablation in an inducible manner (Curado et
al., 2007). Using this model, the authors analyzed regener-
ative responses with a particular focus on the atrium, as
Figure 2 Transdifferentiation of atrial myocytes to ventricular muscle. After massive genetic ablation of ventricular muscle (left),
Notch signaling is activated in atrial endocardial cells with upregulation of multiple heart field markers in the entire heart (middle).
Notch signaling indirectly regulates the transdifferentiation of amhc+ myocytes to vmhc+ myocardium possibly through intermediate
proliferative progenitor-like cells expressing cardiogenic transcription factors (right). The figure is a summary of the work by Chi and
colleagues (Zhang et al., 2013).
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proliferate in response to ventricular injury in vertebrate
hearts (McDonnell and Oberpriller, 1983, 1984; Oberpriller
et al., 1987). Ablation was induced in zebrafish embryos at
3–4 days post-fertilization, an early developmental stage in
which cardiac chamber specification is completed. The
results suggest that new ventricular cardiomyocytes arise
from the area adjacent to the atrioventricular canal (AVC)
and expand across the chamber to restore lost ventricular
myocardium. Inducible genetic lineage tracing using the
regulatory sequences of atrial myosin heavy chain (amhc)
gene, also known as myosin heavy chain 6 (myh6) gene, and
live-imaging analyses provided evidence that amhc+ atrial
cardiomyocytes acquire ventricular muscle fate and mi-
grate into the injured area to restore lost ventricular muscle
(Zhang et al., 2013) (Fig. 2, right panel). When ablation was
induced in the adult heart, amhc+ cardiomyocytes did not
give rise to ventricular muscle (Zhang et al., 2013),
suggesting that the atrial-to-ventricular transdifferentiation
is an age-dependent mechanism.
To understand the molecular mechanism of this event,
the authors performed gene expression analyses and found
that ventricular injury induces the expression of the genes
for Notch1b and its ligand DeltaD in the atrium, concomitant
with re-induction of various heart field markers in the entire
heart. Pharmacological inhibition of Notch signaling im-
paired the recovery of ventricular morphology and function
of the ablated heart, indicating that the Notch pathway is
essential for the regeneration mechanism. Interestingly, the
analysis of a transgenic strain in which Notch signaling activity
can be monitored by reporter gene expression revealed that
this signaling pathway is activated in the atrial endocardium,
suggesting that atrial-to-ventricular transdifferentiation is
indirectly regulated by the endocardium through the Notch
pathway (Zhang et al., 2013) (Fig. 2, middle and right panels).Regulations by epicardial and endocardial cells
Organ-wide injury responses
Injury responses in the zebrafish heart are initiated in an
organ-wide manner before restricting to the wound area. All
major cardiac tissues – epicardium, endocardium, and myocar-
dium – employ this strategy in response to injury (Kikuchi et al.,
2010, 2011b; Lepilina et al., 2006). Within an hour of injury,endocardial cells throughout the heart undergo morphological
changes, such as rounding up and detachment from myocardial
cells, and induce the expression of developmentalmarker genes
such as raldh2 (retinal aldehyde dehydrogenase 2), also known
as alh1a2 (aldehyde dehydrogenase 1 family, member A2), and
heg (heart of glass) in the entire heart by 3 h post-injury
(Kikuchi et al., 2011b). Similarly, the whole epicardium
upregulates tbx18 (T-box transcription factor 18) and raldh2
expression by 3 days post-trauma (Lepilina et al., 2006). By
7 days after injury, the myocardium activates gata4 regula-
tory sequences in the lateral wall of the ventricle, which is
now defined as the cortical muscle layer (Gupta et al., 2013;
Kikuchi et al., 2010). At different time points, depending on
the cell type, these global expression signatures regress
although they are maintained at the injury site, where they
aid or indicate cardiac muscle regeneration (Kikuchi and Poss,
2012).
The organ-wide activation pattern is not limited to the
induction of developmental marker genes. As mentioned in
later sections, Fibronectin, a major component of extracel-
lular matrix, as well as inflammatory cytokines and their
downstream signaling molecules have also been shown to
follow organ-wide activation patterns during zebrafish heart
regeneration (Fang et al., 2013; Wang et al., 2013). The
mechanisms underpinning these responses remain unclear;
however, when zebrafish were intraperitoneally injected with
the inflammatory agent Lipopolysaccharide, raldh2 expres-
sion was induced in the entire epicardium and endocardium of
the uninjured heart, indicating that inflammatory signals
might be involved (Kikuchi et al., 2011b). This speculation
seems consistent with the aforementioned organ-wide activa-
tion of inflammatory genes (Fang et al., 2013).
At first sight, it seems natural to imagine that in tissues
that are competent for regeneration, local signals provoked
by injury, control the key regenerative events. However, as
noted, during heart regeneration in zebrafish the response is
first initiated in an area including the injury site but also
distant from the injury. Accumulating evidence suggests that
an organ-wide injury response is neither unique to zebrafish
nor to the heart. Ancient fish Polypterus senegalus also induce
expression of raldh2 in the entire epicardium and endocar-
dium in response to local injury (Kikuchi et al., 2011b). The
neonatal mouse induces cardiomyocyte dedifferentiation
phenotypes (Porrello et al., 2011b) and accumulation of
angiogenicmacrophages (Aurora et al., 2014), not only near the
injury area, but also in the entire ventricle after injury. During
548 K. Kikuchiliver regeneration, partial hepatectomy is known to affect
tissue distant from the trauma and to activate compensa-
tory hepatocyte proliferation in spared lobes (Taub, 2004).
More recently, injury to the tibialis anterior muscle of the
mouse hind limb has been shown to potentiate the
regenerative capacity of satellite cells that reside in the
intact contralateral limb (Rodgers et al., 2014). Thus, the
capacity to respond to distant injury signals might be a
common feature conserved in regenerative animals and
tissues, and might be a key to mounting effective regener-
ative responses against injury.
Neovascularization
After responding to injury in an organ-widemanner, epicardial
and endocardial cells retain the activation signatures at the
wound area to facilitate heart regeneration. A notable
regenerative event to which these cells contribute is cardio-
myocyte proliferation. A number of molecular mechanisms
have been identified whereby epicardial and endocardial cells
stimulate cardiomyocyte proliferation, which will be discussed
separately in a later section. Another important event during
heart regeneration is the establishment of new vasculature. To
date, multiple developmental signaling pathways have been
implicated in this process during zebrafish heart regeneration.
Epicardial cells appear to facilitate the creation of new vascular
components, as in heart development in higher vertebrates
(Gittenberger-de Groot et al., 2000; Mikawa and Fischman,
1992; Mikawa and Gourdie, 1996; Pérez-Pomares et al., 2002;
Tevosian et al., 2000). As mentioned earlier, the results of
genetic fate mapping analysis and transplantation have
revealed that epicardial cells do not readily acquire endothelial
fate, but rather contribute to perivascular components
(González-Rosa et al., 2012; Kikuchi et al., 2011a).
Moreover, they likely also promote the formation of new
vasculature during regeneration through paracrine mecha-
nisms, as observed during the repair of infarcted mouse
hearts (Zhou et al., 2011). Members of the fibroblast growth
factor (Fgf) signaling pathway are upregulated after resection
injury and this pathway seems to be involved in the repair
process. The expression of Fgf ligand gene fgf17b is induced in
injured myocardium, and Fgf receptor genes fgfr2 and fgfr4
are correspondingly upregulated in epicardial cells within the
regenerate. Inhibition of Fgf signaling by transgenic overex-
pression of a dominant-negative Fgfr inhibits epicardial cell
integration into the wound area and also blocks neovascular-
ization, which leads to regeneration arrest and scar formation
(Lepilina et al., 2006). Platelet-derived growth factor (Pdgf)
signaling also seems to be important during regeneration. The
expression of a Pdgf receptor gene pdgfrβ is induced in the
regenerating heart and pharmacological blockade of receptor
function inhibits proliferation in epicardial cells and coronary
vasculature formation (Kim et al., 2010). Thus, both Fgf and
Pdgf signaling appear to reactivate vascular development
during heart regeneration in zebrafish.
Cardiomyocyte migration
As described above, the lineage tracing studies have demon-
strated that cardiomyocytes generate newmyocardium through
proliferation; however, the mechanism by which proliferatingcardiomyocytes integrate into the wound area remains poorly
understood. Kawakami and colleagues have recently shown that
epicardial cells provide a critical support for cardiomyocyte
migration during regeneration (Itou et al., 2012). The authors
found that after apical resection of the ventricle, a chemokine
ligand gene cxcl12a is transiently induced in epicardial cells
between 3 and 5 days after trauma, concomitantly with the
expression of its receptor cxcr4b in cardiomyocytes. The
authors performed loss-of-function analyses of the Cxcr4
pathway using either pharmacological inhibition of Cxcr4 or
in cxcr4b null mutant zebrafish, and observed less integra-
tion of tissue stained for muscle myosin at the wound area.
Interestingly, with Cxcr4 inhibition, the total extent of
cardiomyocyte proliferation, neovascularization, and fibrin
clearance – phenotypes relevant to regeneration – was
normal. Instead, the ratio of proliferating cardiomyocytes
in the wound area versus other regions appeared signifi-
cantly reduced, suggesting that migration of proliferating
cardiomyocytes is impaired. This hypothesis was directly
addressed using a new transgenic strain in which a
photoconvertible fluorescent reporter, Kaede (Ando et
al., 2002), is specifically expressed in cardiomyocytes. In
this strain, irradiation can permanently convert native
green fluorescence of the reporter to red fluorescence, which
enables tracing of the behavior of irradiated cardiomyocytes
during regeneration. After injury, photolabeled cardiomyocytes
bordering the edge of the lesion did not relocate into thewound
area in the presence of Cxcr4 inhibition at all time points
analyzed (Itou et al., 2012). This result indicates that epicardial
cells contribute to heart regeneration in part by regulating
cardiomyocyte migration through chemokine signaling.
The extracellular matrix is the non-cellular tissue
structure that provides essential scaffolds for cell growth
and differentiation. The importance of extracellular matrix
for the formation of cardiac muscle is highlighted by the
demonstration that a de-cellularized rat cardiac matrix can
reconstitute a beating heart-like organ when re-seeded with
neonatal cardiac cells (Ott et al., 2008). A recent study
published by Wang et al. has found that during zebrafish
heart regeneration, extracellular matrix deposition is dynam-
ically regulated by epicardial cells and this is essential for new
myocardium to be properly restored in the ventricular wall
(Wang et al., 2013). Using a proteomics approach, the authors
found that the production of Fibronectin, a major component
of the extracellular matrix, is prominently upregulated in the
regenerating zebrafish heart. Histological analyses revealed
that expression of fibronectin paralogous genes, fn1 and fn1b,
is initially induced in the epicardium in the entire heart and
then localized to the wound area, whereas the integrin
gene, itgb3, encoding a Fibronectin receptor, is expressed
in cardiomyocytes. With Fibronectin loss-of-function, which
can be induced either with a temperature sensitive mutant
allele of fn1 (Trinh and Stainier, 2004) or by expressing
dominant-negative Fibronectin, new myocardium was not
properly formed in the wound area after apical resection.
Interestingly, cardiomyocyte proliferation was not impaired
by Fibronectin knockdown, a phenotype reminiscent of the
migration defect described above, indicating that Fibronectin is
not required for promoting cardiomyocyte proliferation. Thus,
epicardial cells play a critical role in establishing and providing
extracellular matrix cues that support heart regeneration in
zebrafish.
Figure 3 Signaling pathways regulating cardiomyocyte proliferation during zebrafish heart regeneration. See text for details.
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cardiomyocyte proliferationPositive regulators
Given the identification of existing cardiomyocytes as the
dominant source for regenerating myocardium, the mecha-
nism of cardiomyocyte proliferation is increasingly recog-
nized as a major area of interest within the field. Thus far, a
number of pathways that positively regulate cardiomyocyte
proliferation have been identified (Fig. 3). Upon injury,
retinoic acid (RA) synthesis (Kikuchi et al., 2011b) and
expression of various developmental growth factor genes such
as transforming growth factor β1 (Chablais and Jaźwińska,
2012), pdgf (Lien et al., 2006), sonic hedgehog (Choi et al.,
2013), and insulin-like growth factor 2b (Choi et al., 2013;
Huang et al., 2013) are upregulated at the injury site, where
these factors promote proliferation of cardiomyocytes. The
expression of Notch family genes, notch1a, notch1b, and
notch3, has also been shown to be induced in epicardial and
endocardial cells at the injury site (Raya et al., 2003; Zhao
et al., 2014). Interestingly, cardiomyocyte proliferation and
myocardial regeneration are similarly impaired by either
inhibiting or activating the Notch pathway, indicating that
the balance between activation and inhibition of Notch
signaling is critical for a successful regeneration of the
zebrafish heart (Zhao et al., 2014).
Molecular mechanisms of cardiomyocyte proliferation
have been addressed by unbiased gene expression analyses
(Lien et al., 2006; Sleep et al., 2010). However, since the
heart is highly heterogeneous in cellular components, gene
expression changes in cardiomyocytes would be better pursued
by a myocardial-specific approach. One such approach is
translating ribosome affinity purification (TRAP), which can
enrich cell type specific mRNAs by transgenically expressing
EGFP-tagged ribosomal proteins under a tissue-specific promot-
er and purifying polysomal mRNAs using anti-EGFP antibodies
(Heiman et al., 2008). Fang et al. have recently applied this
technology to obtain gene expression profiles of regeneratingcardiomyocytes (Fang et al., 2013). In the resulting profiles, the
most prominently upregulated genes upon injury were involved
in the Jak1 (Janus kinase1)/Stat3 (signal transducer and
activator of transcription 3) pathway, including il6st (interleu-
kin 6 signal transducer), a cytokine receptor gene, jak1, stat3,
and a Stat3 target gene socs3b (suppressor of cytokine signaling
3b). The expression of multiple Il6st co-receptor genes was also
confirmed, but interestingly, the zebrafish paralog of the OSM
receptor, a molecule regulating dedifferentiation phenotypes
in mammalian cardiomyocytes (Kubin et al., 2011), was not
detected. As mentioned above, the expression of these genes
followed an organ-wide activation pattern: expression was
initially induced in the entire heart, then maintained in the
vicinity of the regenerating myocardium.
To perform cardiomyocyte-specific loss-of-function analy-
sis of the Stat3 pathway, the authors generated a transgenic
line that enables inducible expression of dominant-negative
Stat3 (dnStat3) after excision of loxP-flanked stop sequences,
and crossed this line with the cmlc2:CreER line (Kikuchi et al.,
2010). Regeneration experiments revealed that with Stat3
inhibition, cardiomyocyte proliferation was reduced to nearly
20% of the control level and myocardial regeneration was
blocked with the formation of massive collagenous scar tissue
at the injury site, indicating that myocardial Stat3 function is
essential for cardiomyocyte proliferation and regeneration.
Further gene expression analyses of the hearts expressing
dnStat3 revealed that Stat3 function is required for the
production of Relaxin 3a (Rln3a), a Relaxin family hormone
that activates cAMP dependent pathways through G protein-
coupled receptors (Hsu et al., 2002). Chromatin immuno-
precipitation showed that Stat3 is recruited to the rln3a
promoter upon cardiac injury, and injection of recombinant
human RLN3 peptides partially rescued the impaired
myocardial proliferation in the presence of dnStat3. Thus,
Stat3 regulates cardiac muscle regeneration by promoting
myocardial release of a paracrine factor, Rln3a, which in
turn induces regenerative proliferation of cardiomyocytes
(Fang et al., 2013).
The systemic environment of the body and its overall
physiology can be altered after injury, and this may play a
550 K. Kikuchisignificant role in cardiac regeneration. Given the high oxygen
demand in contracting myocardium, one of the environmental
changes that is likely to occur in the heart after injury is an
insufficient oxygen supply due to reduced cardiac function.
Belmonte and colleagues have recently addressed how the
low oxygen condition, hypoxia, affects heart regeneration in
zebrafish (Jopling et al., 2012a). Using hypoxyprobe, a chemical
reagent that can be used to visualize hypoxic cells, the authors
showed that hypoxia, while ubiquitous in injured ventricular
tissue, was more elevated within the clot and injury border
zone areas, where regeneration events are taking place. Since
one of the cell types at the injury site with enhanced
hypoxyprobe signal was confirmed as cardiomyocytes, the
authors next examined the effect of hypoxia on cardiac muscle
regeneration. To mimic systemic hypoxia, the authors induced
severe anemia by treating zebrafish with Phenylhydrazine, a
hemolytic chemical reagent, and found that cardiomyocyte
proliferation was elevated during regeneration in the anemic
zebrafish. Consistently, hypoxic culture conditions increased
the number of cardiomyocytes in mitosis and showing dediffer-
entiation phenotypes in vitro, whereas hyperoxic conditions
strongly inhibited cardiomyocyte proliferation both in vitro and
in vivo. Collectively, these results suggest that environmental
oxygen concentration is a critical factor for heart regeneration
in zebrafish.
The cellular response to hypoxia is regulated by a family of
transcription factors, hypoxia-inducible transcription factors
(Hifs), which consist of α and β subunits that form stable
heterodimers under hypoxic conditions and activate genes
for cellular adaptations to low oxygen (Semenza, 2014). A
transgenic strain was generated that enables conditional
Cre-dependent myocardial expression of a dominant-negative
form of Hif1α (dnHif1α), and crossed with a muscle-specific
inducible Cre driver strain (Jopling et al., 2010). With dnHif1α
expression, DNA synthesis of cardiomyocytes was reduced and
myocardial regeneration appeared to be incomplete at
30 days after injury, indicating that Hif1α-mediated signal-
ing is positively regulating cardiac muscle regeneration in
zebrafish.
Sadek and colleagues have recently reported that the
oxygen-rich environment of the postnatal mammalian heart
contributes to the generation of reactive oxygen species
(ROS), and have shown that ROS induces oxidative DNA
damage and subsequently a DNA damage response, contrib-
uting to cell cycle arrest in mammalian cardiomyocytes
(Puente et al., 2014). By contrast, such responses seem to be
prevented in the regenerative zebrafish heart, likely due to
low-oxygen saturation of the aquatic environment that they
live in and the inherently low oxidative metabolism of
zebrafish cardiomyocytes (Puente et al., 2014). As described
above, the level of hypoxia is elevated in the vicinity of
regenerating area in the zebrafish heart, which might help to
further prevent the activation of the DNA damage response in
proliferating cardiomyocytes.Negative regulators
Compared to positive regulations, negative regulators of the
regenerative proliferation of cardiomyocytes in zebrafish have
not been well characterized (Fig. 3). One of the molecular
mechanisms that contributes to cell cycle arrest in postnatalmammalian cardiomyocytes is the activity of p38 MAP kinase
(p38 MAPK) (Engel et al., 2006, 2005). p38 MAPK activation
inversely correlates with growth of mammalian hearts and its
inhibition increasesmitosis in adultmammalian cardiomyocytes
both in vitro and in vivo (Engel et al., 2005). A recent
zebrafish study has also reported that phosphorylated-p38
Mapk, an activated form of this kinase, is present in the
nuclei of non-proliferating cardiomyocytes, but disappears
when cardiomyocytes enter the mitotic cycle in vitro and in
vivo (Jopling et al., 2012b). When a constitutively active form
of Mkk6, an upstream kinase in the p38 Mapk pathway, was
overexpressed in the myocardium, cardiomyocyte prolifera-
tion was severely impaired and cardiogenesis did not occur
at the wound area. These results suggest that p38 Mapk also
plays a crucial role in the negative regulation of cardio-
myocyte proliferation during heart regeneration in
zebrafish.
MicroRNAs (miRNAs) are increasingly recognized as critical
regulators in diverse biological processes, including the prolif-
erative arrest of cardiomyocytes in the postnatal mammalian
heart (Liu et al., 2008; Porrello et al., 2011a). Yin et al. have
recently reported that miRNAs show dynamic regulation during
cardiac regeneration and contribute to modulating cardiomyo-
cyte proliferation (Yin et al., 2012). The authors performed
unbiased miRNA expression analyses comparing uninjured and
injured ventricles, and identified expression changes of
many miRNAs in response to injury. One showing differential
expression was miR-133, which has been shown to suppress
caudal fin regeneration in zebrafish (Yin et al., 2008) and
mammalian orthologs of which contribute to cardiac develop-
ment and diseases (Liu et al., 2008; Wystub et al., 2013).
Validation experiments revealed that miR-133 is expressed in
cardiomyoctyes and its expression inversely correlates with
the progress of heart regeneration in zebrafish, suggesting an
inhibitory role on heart regeneration. When miR-133 was
overexpressed under the control of heat-inducible promoter
sequences, cardiomyocyte proliferation was reduced at the
wound area by nearly 50%, and myocardial regeneration was
blocked with the formation of collagenous scar. By contrast,
when miR-133 was depleted by expressing target-specific
miRNA “sponge” sequences, which contain triplets of perfect-
ly matched binding sites for miR-133, the proliferation of
cardiomyocytes was elevated throughout the regeneration
process, even at 30 days after injury, a time point at which
regenerative responses are largely complete.
Using injured ventricular samples with or without miR-133
function, gene expression analyses were performed to identify
miR-133 target genes during regeneration. In addition to
various known regulators of the cell cycle machinery, the
authors found that the expression of cell junction molecule
genes was significantly changed depending on miR-133
expression. One of these, connexin 43 (cx43) was particu-
larly interesting, as it had not been reported as a target
gene for miR-133 or its close relatives. A sensor assay using a
reporter construct containing cx43-3′UTR sequences con-
firmed that cx43 is an in vivo target of miR-133, and
pharmacological inhibition of Cx43 suppressed cardiomyo-
cyte proliferation in the injured ventricle. Although the
mechanism by which Cx43 regulates regeneration needs
further investigation, these results indicate that miR-133
negatively regulates cardiomyocyte proliferation, partly
through modulating Cx43 level (Yin et al., 2012).
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The view of the mammalian heart as a post-mitotic organ with
no regenerative capacity has been revised as a result of recent
studies. The neonatal mouse heart has been shown to possess
robust regenerative capacity during a short window of time
after birth (Porrello et al., 2011b). This capacity diminishes
within a week, which seems to coincide with binucleation and
loss of proliferative capacity of cardiomyocytes (Laflamme and
Murry, 2011). In contrast, the majority of cardiomyocytes are
mononucleated in the zebrafish heart (Wills et al., 2007). In the
adult mouse heart, a small population of mononucleated
cardiomyocytes has been shown to proliferate in the presence
of growth factor stimulation (Bersell et al., 2009), supporting
the notion that mononucleation is a prerequisite for cardio-
myocyte proliferation. However, a recent study has reported
the surprising finding that bothmononucleated and binucleated
mouse cardiomyocytes retain robust proliferative capacity
beyond the neonatal period, being temporarily reactivated at
postnatal day 15, and contributing to a substantial increase in
new cardiomyocytes in the preadolescent heart (Naqvi et al.,
2014). Significant proliferation of cardiomyocytes does not
seem to occur after this period, but it has been recognized that
the heart maintains self-renewal capacity at a measurable level
throughout life (Bergmann et al., 2009; Senyo et al.,
2013). Collectively, these findings illuminate the possibil-
ity of reactivating endogenous regenerative capacity in the
human heart as a novel therapeutic strategy to treat
cardiac diseases.
Successful stimulation of endogenous regenerative capac-
ity in injured human hearts will benefit from studies discussed
above on the robust regenerative responses observed in the
adult zebrafish heart. Previous genetic fate-mapping studies
have shown that the zebrafish heart utilizes cardiomyocyte
proliferation as the dominant mechanism to regenerate
myocardium. Understanding intrinsic and extrinsic molecu-
lar signals that control cardiomyocyte proliferation and
differentiative quiescence in this model will have direct
implications for how regeneration can be stimulated in the
injured human heart through cardiomyocyte proliferation.
Chemical genetics approaches are an interesting strategy to
dissect suchmechanisms, whichmay be facilitated by recently
developed transgenic reporter strains in which cardiomyocyte
proliferation and regeneration can be monitored in live
animals (Chen et al., 2013; Choi et al., 2013). Novel lineage
tracing studies have identified several previously unknown
sources for regenerating muscle, which will promote further
inquiry into the cellular mechanism of heart regeneration.
Identifying pathways affecting non-myocytes such as epicar-
dial and endocardial cells, will provide further interesting
molecular candidates that modulate cardiomyocyte prolifer-
ation, migration or neovascularization. Results obtained from
the zebrafish model will complement those from other models
and contribute valuable insights for better understanding heart
regeneration toward the ultimate goal of treating heart failure.
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